Green PEGylated-Sily@ZnFe2O4 nanocomposites for amelioration of ROS and DNA damage in rat liver.
Ontology highlight
ABSTRACT: Some conventional drugs are swiftly accessible and poorly soluble in the body. Although it is less soluble and accessible, silymarin, a well-known antioxidant drug, is used to treat several ailments. It is integrated into green-designed Fagonia cretica extract (FCE) based on PEGylated-Sily@ZnFe2O4 in this work to enhance these characteristics. UV-visible spectrometry, X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), and zeta potential analysis were all used to thoroughly analyze the nanocomposites. As a result, ZnFe2O4 nanocomposites (NCs) produced nanostructures with an average crystal size of 7.66 nm, whereas PEGylated-Sily@ZnFe2O4 nanodrug produced with an averag
SUBMITTER: Waqas M
PROVIDER: S-EPMC12322044 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA